Survival outcomes in esophageal cancer treatment Esophageal cancer, concurrent chemoradiation, esophagectomy
Conditions
Interventions
Locally advanced esophageal cancer patients who treated with preoperative concurrent chemoradiation followe by surgery ,Locally advanced esophageal cancer patients who treated with definitive chemorad
Treatment,Treatment
Preoperative concurrent chemoradiation followe by surgery ,Definitive chemoradiation
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Locally advanced esophageal carcinoma 2. Histlogic reported with squamous cell carcinoma or adenocarcinoma 3. receive concurrent chemoradiation between January 1, 2013, and December 31, 2022
Exclusion criteria
Exclusion criteria: 1.Patients who were diagnosed with cervical part esophageal cancer 2. Palliative aim treatment 3. Treatment with radiotherapy alone 4. Receive upfront esophagectomy 5. Metastatic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival 2 years after treatment date of diagnosis to date of death , alive, death | — |
Secondary
| Measure | Time frame |
|---|---|
| progression free survival 2 years after treatment date of diagnosis to date of progression/ date of medical reviewed, no progression/ progression | — |
Countries
Thailand
Contacts
Public ContactSomvilai Chakrabandhu
Faculty of Medicine, Chiang Mai University
Outcome results
None listed